| List | Section | Observation |
|---|---|---|
| Chile. Formulario Nacional de Medicamentos. 2005 | 07.02. INMUNOSUPRESORES |
Others observations: Alternativa |
| List | Section | Observation |
|---|---|---|
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | L. AGENTES ANTINEOPLÁSICOS E IMUNOMODULADORES | No observations |
| Chile. Formulario Nacional de Medicamentos. 2005 | 07.02. INMUNOSUPRESORES |
Others observations: Alternativa |
| List | Section | Observation |
|---|---|---|
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Immunosuppresive Agents | No observations |
| Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. |
Others observations: X 60 TABLETAS |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | L. AGENTES ANTINEOPLÁSICOS E IMUNOMODULADORES | No observations |
| Chile. Formulario Nacional de Medicamentos. 2005 | 07.02. INMUNOSUPRESORES |
Others observations: Alternativa |
| List | Section | Observation |
|---|---|---|
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | L. AGENTES ANTINEOPLÁSICOS E IMUNOMODULADORES | No observations |
| Chile. Formulario Nacional de Medicamentos. 2005 | 07.02. INMUNOSUPRESORES |
Others observations: Alternativa |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 8.2.2 Targeted therapies | No observations |
| List | Section | Observation |
|---|---|---|
| Mexico. Cuadro Basico de Medicamentos - 2017 | 17. ONCOLOGIA | No observations |
| WHO Model List of Essential Medicines (2021) | 8.2.2 Targeted therapies | No observations |
| List | Section | Observation |
|---|---|---|
| Mexico. Cuadro Basico de Medicamentos - 2017 | 17. ONCOLOGIA | No observations |
| WHO Model List of Essential Medicines (2021) | 8.2.2 Targeted therapies | No observations |
| List | Section | Observation |
|---|---|---|
| Mexico. Cuadro Basico de Medicamentos - 2017 | 17. ONCOLOGIA | No observations |
| WHO Model List of Essential Medicines (2021) | 8.2.2 Targeted therapies | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 8.2.2 Targeted therapies | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 8.2.2 Targeted therapies | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 8.2.2 Targeted therapies | No observations |